Sequenom Aktie
WKN DE: 932193 / ISIN: US8173371084
03.12.2014 12:11:48
|
Illumina & Sequenom Pool NIPT Intellectual Property, End Patent Disputes
(RTTNews) - Illumina, Inc. (ILMN) and Sequenom, Inc. (SQNM) Wednesday said they have agreed to settle all pending infringement claims and other disputes between Sequenom and Verinata Health, Inc.
The parties will pool their owned and in-licensed intellectual property directed to noninvasive prenatal testing or NIPT, including patents that will remain the subject of ongoing interference proceedings.
Under the agreement, Illumina will have exclusive worldwide rights to utilize the pooled intellectual property to develop and sell in-vitro diagnostic kits for NIPT and to license third-party laboratories wishing to develop and sell their own laboratory-developed NIPT tests under the collection of pooled patents.
Further, Sequenom and Illumina will each have rights to utilize all pooled patents to develop and sell their own respective laboratory-developed NIPT tests.
The parties will share the revenue from the patent pool and Illumina will pay Sequenom a royalty on sales of in-vitro diagnostic kits for NIPT.
Illumina will make a $50 million upfront payment to Sequenom as part of the overall agreement, as well as certain ongoing commitments for payments to Sequenom from the patent pool structure through 2020.
Separately, Illumina and Sequenom entered into an amended supply agreement whereby Illumina agreed to supply Sequenom with instruments and reagents for an additional five years.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Illumina Inc.mehr Nachrichten
23.05.25 |
S&P 500-Papier Illumina-Aktie: So viel Verlust hätte ein Illumina-Investment von vor 3 Jahren eingebracht (finanzen.at) | |
16.05.25 |
NYSE-Handel: S&P 500 klettert (finanzen.at) | |
16.05.25 |
S&P 500-Papier Illumina-Aktie: So viel Verlust hätte ein Investment in Illumina von vor einem Jahr bedeutet (finanzen.at) | |
09.05.25 |
Angespannte Stimmung in New York: S&P 500 beendet die Sitzung weit in der Verlustzone (finanzen.at) | |
09.05.25 |
Börse New York: S&P 500 am Mittag fester (finanzen.at) | |
09.05.25 |
S&P 500-Wert Illumina-Aktie: So viel Verlust hätte ein Illumina-Investment von vor 10 Jahren eingebracht (finanzen.at) | |
09.05.25 |
S&P 500-Handel aktuell: S&P 500 beginnt Handel mit Gewinnen (finanzen.at) | |
07.05.25 |
Ausblick: Illumina stellt Zahlen zum jüngsten Quartal vor (finanzen.net) |
Analysen zu Sequenom Inc.mehr Analysen
Aktien in diesem Artikel
Illumina Inc. | 72,39 | 1,17% |
|